CareDx, Inc (NASDAQ:CDNA) Receives $16.50 Average Target Price from Analysts

CareDx, Inc (NASDAQ:CDNA – Get Free Report) has received an average rating of “Moderate Buy” from the five brokerages that are presently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month price objective among […]

Leave a Reply

Your email address will not be published.

Previous post Cadre Holdings, Inc. (NYSE:CDRE) Given Average Recommendation of “Moderate Buy” by Analysts
Next post REGENXBIO (NASDAQ:RGNX) Upgraded by StockNews.com to “Hold”